UK companies struggling with Reach


Companies in the UK are failing to recognise the implications of the Reach (registration, evaluation and authorisation of chemicals) regulation, according to a report by EEF, a UK industry group.

Of the manufacturers surveyed, 20% believed that the regulation did not apply to them and 30% believed it wasn’t important to their business. The situation seems worst for smaller companies: even when they were aware of the Reach regulation, half said they were not monitoring developments. This compares with 72% of large companies and 83% of medium sized ones monitoring developments.

Cost and complexity were cited as the root of the problem, with 20% of companies reporting that for them the time dedicated to dealing with the regulation had increased significantly in the last two years.

EEF says that for UK manufacturers the Reach regulation is the ‘elephant in the room’. Companies that fail to comply could face unlimited fines or even prison. As such, the organisation wants to see the government do more to raise awareness of the implications on businesses.

‘The regulations have serious requirements for all manufacturers, who are facing either the restricted use or banning altogether of some substances,’ said Gareth Stace at EEF. ‘For many companies, there is the very real risk of lost business if they are unable to advise their customers whether their products contain certain materials and, where they are, how their use is being monitored.’


Related Content

All hail shale

7 January 2014 Business

news image

Chemical industry roundup 2013

A chemical regulation comes of age

23 December 2010 News Archive

news image

For the European chemical industry, 2010 was all about registration under the Reach regulation, the focus of our roundup

Most Read

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

The mothers of invention

24 February 2015 Managing Change

news image

Nina Notman profiles four researchers successfully balancing an academic career with family life

Most Commented

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Hepatitis C drug patent challenged in Europe

19 February 2015 Business

news image

Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent